| Current Price | $0.31 | Mkt Cap | $13.5M |
|---|---|---|---|
| Open | $0.31 | P/E Ratio | -0.14 |
| Prev. Close | $0.31 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.29 - $0.34 | Volume | 283,285 |
| 52-Wk Range | $0.25 - $7.70 | Avg. Daily Vol. | 413,754 |
| Current Price | $0.31 | Mkt Cap | $13.5M |
|---|---|---|---|
| Open | $0.31 | P/E Ratio | -0.14 |
| Prev. Close | $0.31 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.29 - $0.34 | Volume | 283,285 |
| 52-Wk Range | $0.25 - $7.70 | Avg. Daily Vol. | 413,754 |
The best Bull and Bear pitches based on recency and number of recommendations.
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock… More
Read the most recent pitches from players about EIGR.
Recs
oscillation
(74.16)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-200.34
nev
Recs
treasureoaks
(< 20)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-202.80
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-205.14
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
GreenAB (30.43) Score: +203.53
The Score Leader is the player with the highest score across all their picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 30.43 | 3/20/2015 |
|
NS | $405.00 | -99.92% | +103.61% | +203.53 | 0 Comment | |
| IdahoInvestor | 99.67 | 8/17/2015 |
|
5Y | $15.75 | -97.97% | +104.82% | +202.79 | 0 Comment | |
|
OneBee | < 20 | 5/4/2021 |
|
3M | $8.67 | -96.31% | +2.73% | -99.04 | 0 Comment |
| foggs1 | 60.01 | 3/17/2021 |
|
5Y | $10.12 | -96.84% | +8.35% | -105.19 | 0 Comment | |
| odocoileus | < 20 | 9/10/2020 |
|
5Y | $10.48 | -96.95% | +27.63% | -124.57 | 0 Comment | |
| drugtrader | 51.09 | 7/8/2020 |
|
5Y | $9.43 | -96.61% | +36.64% | -133.24 | 0 Comment | |
| naughtyguy | 97.20 | 8/21/2019 |
|
5Y | $10.56 | -96.97% | +46.32% | -143.29 | 0 Comment | |
|
|
jeepdrew222 | 36.06 | 8/28/2018 |
|
5Y | $12.90 | -97.52% | +47.25% | -144.77 | 0 Comment |
| BigDreamer | 52.08 | 1/29/2018 |
|
3Y | $8.95 | -96.42% | +49.51% | -145.93 | 0 Comment | |
| skyrocket29 | 66.06 | 1/16/2018 |
|
3M | $9.10 | -96.48% | +52.81% | -149.29 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
